. One interpretation of these data is that LTP internal perfusion of CaMKII* increased synaptic strength in rat hippocampal neurons and diminished the fraction of synaptic fail-can be expressed predominantly by non-NMDA receptors. LTP (Silva et al. 1992). Increased postsynaptic activity of increasing the available number of active a-amino-3-hydroxy-5-CaMKII potentiates synaptic transmission and occludes furmethylisoxazole-4-propionic acid/kainate channels and suggests ther LTP (Pettit et al. 1994) . In frog optic tectum, increased that a similar process may occur during the expression of long-postsynaptic CaMKII selectively potentiates a-amino-3-hyterm potentiation.
Shirke, Aneil M. and Roberto Malinow. Mechanisms of potentia-coll 1992; Larkman et al. 1992; Liao et al. 1992 ; Stricker tion by calcium-calmodulin kinase II of postsynaptic sensitivity in et al. 1996) . Other work has shown that synaptic transmisrat hippocampal CA1 neurons. J. Neurophysiol. 78: 2682 Neurophysiol. 78: -2692 , sion at hyperpolarized potentials undergoes LTP with a de-1997. Preactivated recombinant a-calcium-calmodulin dependent crease in failure rate (Kullmann and Nicoll 1992; Malinow multifunctional protein kinase II (CaMKII*) was perfused inter-1991; Malinow and Tsien 1990; Stevens and Wang 1994) , nally into CA1 hippocampal slice neurons to test the effect on whereas transmission at depolarized voltages largely is unafsynaptic transmission and responses to exogenous application of fected (Isaac et al. 1995; ; but see Kullmann glutamate analogues. After measurement of baseline transmission, et al. 1996) . One interpretation of these data is that LTP internal perfusion of CaMKII* increased synaptic strength in rat hippocampal neurons and diminished the fraction of synaptic fail-can be expressed predominantly by non-NMDA receptors.
ures. After measurement of baseline responses to applied transmitThe calcium-calmodulin multifunctional protein kinase II, ter, CaMKII* perfusion potentiated responses to kainate but not (CaMKII) is a likely postsynaptic effector of this form of responses to N-methyl-D-aspartate. Internal perfusion of CaMKII* plasticity. It is the most common protein in the postsynaptic potentiated the maximal effect of kainate. Potentiation by density (PSD) Kennedy et al. 1983 ). CaMKII* did not change the time course of responses to kainate, Protocols that induce LTP increase CaMKII activity (Fukuwhereas increasing response size by pharmacologically manipulatnaga et al. 1993 ) and result in phosphorylation of several ing desensitization or deactivation rate constants significantly alsubstrates (Fukunaga et al. 1995) . Pharmacological block- LTP (Silva et al. 1992) . Increased postsynaptic activity of increasing the available number of active a-amino-3-hydroxy-5-CaMKII potentiates synaptic transmission and occludes furmethylisoxazole-4-propionic acid/kainate channels and suggests ther LTP (Pettit et al. 1994) . In frog optic tectum, increased that a similar process may occur during the expression of long-postsynaptic CaMKII selectively potentiates a-amino-3-hyterm potentiation.
droxy-5-methyl-4-isoxazolepropionic acid (AMPA)-mediated transmission and decreases synaptic failures at hyperpolarized but not depolarized potentials. Quantal size of AMPA
I N T R O D U C T I O N
responses also is increased (Wu et al. 1996) . AutophosphorUnderstanding the mechanism of expression of long-term ylation of CaMKII produces a constitutively active enzyme potentiation (LTP) has been a long-standing problem in the (Hanson and Schulman 1992) that could underlie the persisfield of neurobiology Nicoll and Malenka tence of LTP (Lisman 1994) . Postsynaptic application of 1995) . The means by which synaptic connections are thio-phosphorylated CaMKII (CaMKII*, an in vitro modistrengthened on a long-term basis has implications for learnfication of the enzyme that renders it active and resistant ing and memory (Bliss and Collingridge 1993) , as well as to endogenous phosphatases) has been shown to increase the development of the nervous system (Cline 1991) . One somatic sensitivity to kainate in cultured hippocampal cells proposed mechanism is a change in postsynaptic respon- (Kolaj et al. 1994; McGlade-McCulloch et al. 1993) and to siveness (Bliss and Lomo 1973; Hebb 1949; Lynch and increase the strength of synaptic transmission and mutually Baudry 1984 ; Nicoll and Malenka 1995;  occlude LTP in hippocampal slices (Lledo et al. 1995) . Nicoll et al. 1988) .
Together, these studies provide strong evidence that CaMKII Considerable evidence supports the hypothesis that at least is necessary and sufficient to induce LTP. part of the expression of LTP is mediated by postsynaptic What cellular effects of CaMKII activity could produce changes. LTP can be expressed primarily by non-N-methylsuch changes? The responsiveness of the postsynaptic mem-D-aspartate (NMDA) receptor mediated transmission, (Aszbrane would be expected to depend on the proximity of tely receptors to the release site, the available number of active et Muller and Lynch 1988 Clark and Collingridge 1995; O'Connor et al. 1995;  finity, rate constants among channel states, and single-chan- Xie et al. 1992) . Quantal size, classically thought to be nel conductance. A modification of any of these factors could determined postsynaptically (DelCastillo and Katz 1954) , increases during LTP (Isaac et al. 1996 ; Kullmann and Ni-affect responsiveness, but each also would have additional with 95% O 2 -5% CO 2 (pH 7.4). A cut between the CA3 and CA1 predictable consequences. Current evidence does not distinregions prevented epileptiform activity. During synaptic stimulaguish among these various possibilities. This study examines tion experiments, the bath also contained 100 mM 2-amino-5-phosthe mechanism by which CaMKII potentiates responses in phonovalerate. During experiments in which saturating doses of the hippocampal slice. Specifically, these experiments test kainate were delivered, bath solution contained 0.3 mM tetrodothe hypothesis that increased postsynaptic CaMKII activity toxin. Internal solution contained (in mM) 100 Cs-gluconate, 0.2 increases the available number of active postsynaptic recep-ethylene glycol-bis(b-aminoethyl ether)-N,N,N,N-tetraacetic tors. The evidence that increased postsynaptic CaMKII activ-acid, 5 MgCl 2 , 2 ATP (Na 2 ATP), 0.3 GTP (Na 2 GTP), and 40 Nity underlies LTP argues that a similar mechanism may be 2-hydroxyethylpiperazine-N-2-ethanesulfonic acid (pH 7.2 with responsible for the expression of LTP. Otmakhov et al. 1993) , and were submerged and superfused at experiments with applied agonist, 5 mM 1,2-bis (2-aminophenoxy) 27ЊC. Whole cell recordings were acquired with a patch electrode ethane-N,N,N,N-tetraacetic acid (Molecular Probes, Eugene, (1.5-2.5 MV tip resistance) using an Axopatch 1-D (Axon Instru-OR) and 10 mM Microcystin-LR (RBI, Natick, MA), a phosphaments) and a LM-900 interface (Dagan) operated by a custom tase inhibitor, were added to both patch solution and internal perfuprogram written in a Quickbasic environment (Microsoft) with the sion solution. Cyclothiazide (courtesy of Lilly Pharmaceuticals, Axobasic software library (Axon Instruments). Visualized patchIndianapolis, IN) was prepared as a 10 mM stock solution in 1% clamping was performed with a CCD camera (Hamamatsu) dimethyl sulfoxide and was applied at concentrations of°100 mM. attached to a Zeiss Axioskop fixed-stage microscope mounted on a All chemicals were from Sigma (St. Louis, MO) except where translational stage. Synaptic responses were elicited by monopolar otherwise noted. electrical stimulation of stratum radiatum via a glass microelectrode and a Grass SD9 stimulator. Agonist responses were elicited by pressure injection of receptor agonist (kainate or NMDA) using Analysis a Picospritzer (General Valve) via a patch pipette (Ç7 MV) onto the soma of a CA1 neuron once every 10 s, except for saturation Stimulation artifacts were subtracted digitally from synaptic responses before analysis. Response amplitudes were quantified by experiments when the interval was 20 s. We chose to use kainate to stimulate AMPA/kainate receptors for three reasons: first, kai-calculating the average current during the 10-50 ms around the peak of the response and subtracting the average current during an nate has been used previously to assay the effect of active CaMKII (McGlade-McCulloch et al. 1993) . Second, because AMPA/kai-interval of equal length immediately before the response. Response size after manipulations was measured as a percentage of baseline. nate receptors do not desensitize completely to kainate, examination of steady state responses is possible (Patneau et al. 1993 ). The failure rate was estimated as double the percentage of traces in which the measured response was õ0 pA after adjustment for Third, because kainate is a partial agonist (Patneau et al. 1993) , the maximal response will be smaller and therefore more easily stimulation artifact . Measurements of the rate of decay of responses were produced by least-squares best fit of a measured under voltage-clamp. Any neurotransmitter analogue may act differently from the endogenous transmitter, however. single exponential decay to averaged responses using a LevenbergMarquardt fitting algorithm within the program Origin (Microcal Agonists were delivered at concentrations (in the puffer pipette) of 0.1 mM for both kainate and NMDA, except where explicitly Software). The half-width was measured as the time between half the peak response during the rising phase of the response and half stated. Injection duration was 4-30 ms. Agonist was applied directly onto the soma as has been described previously (McGlade-the peak during the decay phase. Nonstationary fluctuation analysis (Sigworth 1980) was performed by calculating the point-by-point McCulloch et al. 1993; Patneau et al. 1993) . After establishment of stable baseline responses to either synaptic stimulation or agonist mean and standard deviation of a series of traces. The point-bypoint coefficient of variant (CV) is calculated as the standard application, a volume of test (or control) solution approximately equal to the amount of solution initially present in the patch pipette deviation divided by the mean. Theoretically, if N is the number of channels, P is the probability that the channel is open, and i is (Ç4 ml) was perfused into the cell via a small canula placed within the pipette tip.
the single-channel current, then the mean response at any point during the time course of the response is Recording conditions, including holding current, series resistance, and input resistance, were monitored throughout each experim Å Nrpri ment. Occasionally conditions changed slightly during perfusion. Only epochs which had passive properties within 20% of baseline The coefficient of variation is values were included for analysis. In puffing experiments, experiments were excluded if response onset time changed by more CV Å 1 0 p Nrp than 1 ms. Rhodamine-isothiocyanate (RITC)-dextran (40 kD; Molecular Probes) was added to internal perfusion solution (Ç0.1 and mg/ml) as a marker for delivery of internal perfusate. This dextran is similar in molecular weight to recombinant CaMKII (33 kDa).
The fluorophore was excited by a xenon-mercury arc-lamp filtered to 525-550 nm. Quantitative images of emissions ú590 nm were acquired and analyzed using a cooled CCD and PMIS software here the primed terms represent values after potentiation. Note that an increase in i should produce a change in the mean with no (Photometrics).
Superfusate contained (in mM) 119 NaCl, 2.5 KCl, 1.3 MgCl 2 , change in the CV of responses. Mean and CV were computed over 20-50 consecutive responses during the baseline period, and, after 2.5 CaCl 2 , 26.2 NaHCO 3 , 11 glucose, and 0.1 picrotoxin gassed J0286-7 / 9k20$$no58
10-31-97 15:12:04 neupa LP-Neurophys potentiation had stabilized, over the same number of responses before and after maximum potentiation. Baseline noise was subtracted before computation of CV. If the recording was lost before potentiation had stabilized, the data were excluded for this analysis.
For imaging experiments, the average fluorescence of a rectangle encompassing the soma was calculated, and background fluorescence was subtracted. Fluorescence was measured at several points during an experiment. Values were normalized, using the final value as 100%. Regression analysis was performed to compare normalized fluorescence and normalized potentiation.
Simulations
Simulations were done using a simple five-state model for non-NMDA receptor activation ( t-test: n.s., n Å 17). Potentiation by active kinase was sigpaired t-test: P õ 0.05, n Å 6 ) and inactive kinase did not ( 103 { 13%; nificantly different from the effect of inactive kinase (inde-paired t-test: n.s., n Å 6 ). pendent t-test: P õ 0.05, n Å 34). Some of these experiments were performed with K / as the major cation instead of Cs Malinow 1991; Malinow and Tsien 1990 ; with no obvious effect on the results.
Stevens and Wang 1994). As LTP produces a decrease in failure rate (Malinow 1991; Malinow and Tsien 1990) , we wanted to test the effect of CaMKII* on synaptic failures. Stimulus strength was set Enhancement of responsiveness to glutamate analogues by so that synaptic failures (trials in which responses were not CaMKII* distinguishable from the background noise; Fig. 2A ) were detected. As shown in Fig. 2 , perfusion of active CaMKII* Changes in synaptic failure rates traditionally have been interpreted to indicate presynaptic modifications. However, decreased the number of synaptic failures (Fig. 2B ). In this example, response size increased Ç8 min after internal per-more recently, postsynaptic mechanisms have been postulated to explain this finding (Isaac et al. 1995 ; Liao et al. fusion of CaMKII* (Fig. 2C ) with no significant change in series resistance (Fig. 2D) . Quantitative failure analysis 1995). We wanted to examine more closely possible postsynaptic modulations produced by CaMKII*. First, we stud-(see METHODS ) showed a decrease in the failure rate, indicated by a decrease in the magnitude of the peak at 0 pA ied the specificity of CaMKII* potentiation for NMDA or non-NMDA receptor responses. Responses were monitored in histograms of response amplitudes (Fig. 2, E and F) . The decrease in failure rate was a general finding after perfusion under voltage-clamp while glutamate analogues were pressure-applied to the soma. Figure 3 shows an experiment in of active CaMKII* ( Fig. 2G ; before Å 55 { 6.6%, after Å 41 { 8.7%; paired t-test: P õ 0.05, n Å 11). These experi-which kainate and NMDA were puffed alternately. After achieving stable baseline responses to the two agonists of ments show that active CaMKII is sufficient to potentiate synaptic transmission and decrease failure rates, as occurs ¢50 sweeps, CaMKII* was perfused into the patch pipette.
About 10 min subsequent to perfusion, the response to kaiduring LTP (Bolshakov and Siegelbaum 1995; J0286-7 / 9k20$$no58
10-31-97 15:12:04 neupa LP-Neurophys responses (Fig. 3, D-F) . This depression occurred before the appearance of fluorescence (Fig. 3G) n.s., n Å 9) implying that this effect was not produced by CaMKII. This effect may be due to calmodulin, which is included in both test and control internal perfusate and has been shown to depress NMDA responses . No further characterization of this effect was attempted.
Increase of the maximal effect of kainate
To investigate the mechanism of potentiation of kainate responses, several hypothetical mechanisms were tested. CaMKII* might increase responsiveness to kainate via a simple increase in receptor affinity for agonist; however, this hypothesis also implies that responses to a saturating dose of kainate, a measure of maximum efficacy, should not be potentiated by CaMKII* (Fig. 4A , Table 1 ). In contrast, an increase in the number of AMPA/kainate receptors would cause an increase of responses to all concentrations of kainate as well as of the maximal effect of kainate ( (Fig. 4C) . As the duration of over the course of the experiment. E and F: smoothed and binned histograms pressure application was increased, peak response size inof 125 response amplitudes before (E) and after (F) perfusion of CaMKII* creased but eventually reached a plateau (Fig. 4C ). Note show a marked decrease in the magnitude of the peak at 0 pA. A smoothed that when application time was increased further, it only histogram of noise scaled to the 0 pA peak is superimposed. G: thiophosphorylated CaMKII* decreases failure rate (n Å 11; paired t-test: P õ increased the late portion of the response, which was proba-0.05). Graph shows the failure rate before and after potentiation for each bly due to agonist diffusing to sites distant from the applicapathway analyzed. Large circles are the mean failure rates before and after tion site. To ensure that the response to application of 10 perfusion. mM kainate for 20 ms was the maximal effect of kainate, it was compared with the response to 50 mM kainate applied in a similar fashion. Two application pipettes, one containing nate began to grow (Fig. 3, A-C) . Overall, active CaMKII* significantly potentiated responses to kainate ( Fig. 3H ; 10 mM kainate, the other containing 50 mM kainate, were positioned at equal distance from the cell membrane of a 265 { 54%; paired t-test: P õ 0.05, n Å 8), whereas inactive kinase had no significant effect (104 { 21%, paired t-test: patched cell. Responses were evoked from each on alternate trials. Peak responses to 50 mM were not significantly larger n.s., n Å 5). The effect of active kinase was significantly different from inactive kinase (independent t-test: P õ 0.05, than peak responses to 10 mM kainate (Fig. 4D ). This was a consistent finding ( Fig. 4G ; 98 { 2.3% of magnitude of n Å 13). In the experiment shown in Fig. 3 , a fluorescent marker (40 kDa RITC-dextran) was included in the internal responses to 10 mM kainate; paired t-test: n.s., n Å 4).
Perfusion of active CaMKII* potentiated responses to satperfusate. The time course of the increase in fluorescence intensity of marker in the cell body (Fig. 3G) closely urating applications of 10 mM kainate (Fig. 4 , E-G; 116 { 3%, paired t-test: P õ 0.05, n Å 4). In some of these experimatched potentiation of responses to kainate (Fig. 3C ). This was a general finding ( Fig. 3I ; multiple regression analysis: ments, a shorter duration puff was delivered in alternate trials. This shorter duration puff produced a subsaturated P õ 0.05, R Å 0.95, n Å 17).
In contrast to the effect seen on kainate responses, active response (Ç50% of saturated response) that also was potentiated to a similar degree by CaMKII* perfusion (Fig. 4 E-G; 114 { 3%, paired t-test: P õ 0.05, n Å 4). The detected, interpretation of responses must take this into account. increase of the maximal effect of kainate is evidence against a simple change in affinity.
We considered whether these large conductances could compromise the somatic voltage clamp to a degree that Although CaMKII* increased the maximal effect of kainate, the magnitude of potentiation was considerably smaller blunts the amount of potentiation seen of responses to 10 mM kainate compared with responses to lower concentrathan potentiation of responses to 100 mM kainate (see preceding text). We noticed that positioning a puffer pipette tions (100 mM kainate produced responses that were Ç2% of the maximal effect of kainate). To address this issue, we filled with 10 mM kainate close to the soma of a target cell, in the absence of puffing, produced a large standing current used the simulation program NEURON to model the voltageclamp configuration (Fig. 5A ) and the reaction scheme for on the order of 1 nA, reversibly decreasing input resistance from 198.5 { 26.9 to 95.1 { 10.9 MV (paired t-test: P õ AMPA/kainate channel activation (Fig. 5B) . If the fraction of receptors in the open state is large, the membrane resis-0.05, n Å 4). On puffing agonist, the input resistance dropped as low as 30 MV. Exchanging K / for Cs / in inter-tance will decrease markedly. Because the driving force for currents is determined by the ratio of membrane resistance nal solutions did not affect this response. This low resistance, presumably due to activation of AMPA/kainate conduc-to total circuit resistance, the magnitude of large conductances will be proportionately underestimated. Thus potentitances, will compromise the voltage clamp. Note that potenation of large conductances also could be underestimated. tiation of responses to 10 mM kainate is evidence that the voltage-clamp was not completely compromised before apSimulations of various modifications that doubled the magnitude of observed synaptic responses to 100 mM kainate plication of CaMKII*. Thus although potentiation could be J0286-7 / 9k20$$no58 10-31-97 15:12:04 neupa LP-Neurophys produced by doubling the opening rate, ro, from 0.45 to 0.9. To simulate kainate. A: hypothetically, an increase of the binding affinity of the receptor either a doubling of single-channel conductance or of total channel number, would result in a leftward shift of the dose-response curve and could produce maximum conductance was doubled. In simulations, 100 mM agonist propotentiation of subsaturated responses. However, such a change would not duced 0.1% receptor binding and 10 mM agonist produced 99% receptor change the maximal effect of the agonist. B: an increase of receptor number binding. Potentiation is indicated as a percentage of baseline response. could produce potentiation of responses to all concentrations of agonist and would increase the maximal effect of the agonist. C: responses to 10 mM kainate as the puff duration is increased are larger up to the maximal effect of kainate; however, further increases of peak response size are not seen. (Table 1) . This sup-lent circuit for recording configuration. R s is the series resistance, C m is the ports the view that the smaller CaMKII*-induced potentia-membrane capacitance, R i is the passive input resistance of the cell. R A/k is the variable resistance produced by a-amino-3-hydroxy-5-methyl-4-isox- cations of kainate that were well below saturation level.
Analysis of time course of kainate responses before and

J0286-7 / 9k20$$no58
10-31-97 15:12:04 neupa LP-Neurophys did not change their time course (Fig. 6C) . To show that the time course of responses to applied agonist is sensitive to changes in single-channel open time, the kinetics of AMPA/ kainate channels were altered pharmacologically. Cyclothiazide is known to block desensitization and deactivation of non-NMDA receptors (Partin et al. 1993; Patneau et al. 1993) . Blockade of desensitization and/or deactivation has been shown to augment response size and to change the time course of responses to exogenously applied transmitter in isolated preparations (Tang et al. 1991) . Application of cyclothiazide increased the magnitude of responses to puffed kainate and slowed their time course (Fig. 6D) . To quantify the relationship between potentiation and time course changes, the decay rate (tau) and half-width of responses were measured and compared with the magnitude of potentiation (Fig. 6, E and F) . CaMKII* potentiation did not correlate with changes in tau (regression analysis: n.s., R Å 00.01, n Å 6) while cyclothiazide-mediated augmentation was correlated with larger tau values (regression analysis: P õ 0.05, R Å 0.97, n Å 4). CaMKII* potentiation also did not correlate with changes in half-width (regression analysis: n.s., R Å 0.02, n Å 6). Cyclothiazide potentiation correlated with a measurable change in half-width (regression analysis: P õ 0.05, R Å 0.97, n Å 4).
Nonstationary fluctuation analysis of kainate responses before and after CaMKII* perfusion
Nonstationary fluctuation analysis (Sigworth 1980 ) was used to test the hypothesis that CaMKII* potentiates kainate responsiveness by changing single-channel current. Because the number of receptors exposed to agonist is not likely to be FIG . 6 . CaMKII* potentiation of responsiveness to non-NMDA agonists does not change the time course of responses. A: time course of responses constant during an individual response in this experimental changes when puff duration is varied between 6, 9, 12, and 20 ms. Raw paradigm, plots of variance versus mean derived from entire averages are shown top; normalized responses (bottom) show the gross traces were not parabolic. However, over the time course of changes in time course associated with changing the time course of agonist a response, the number of active channels at any point during concentration. B: moving the puffer pipette from 6 mM (thick line) to 3 mM (thin line) produces an increase in the magnitude of the response (top) the time course of a response should be constant from trial to as well as an alteration of the time course ( bottom, normalized). Note the trial. We therefore analyzed the point-by-point CV (standard change in onset time, time to peak, and decay time course. C: CaMKII* deviation divided by mean) around the peak of the response. potentiates responses (top) without changing the time course of responses To determine if this analysis method is sensitive to a modifi- (bottom, normalized) . Heavy line, after potentiation, is nearly superimposcation of single-channel current, the holding potential was able on the scaled fine line, before potentiation. D: cyclothiazide increases response magnitude (top) and slows decay time course (bottom, normal- changed. This is expected to alter the driving force and the ized). E and F: quantitative analysis of time course of responses augmented single-channel current. Changing the driving force from 035 by cyclothiazide () and potentiated by CaMKII* (᭺). Time course mea-to 070 mV increased average response size, but had no sures (E: decay tau; F: half-width) normalized to baseline values are plotted effect on the CV (Fig. 7A) , as expected (Hille 1992). If against normalized amplitude increase. CaMKII* potentiates kainate responsiveness by increasing the single-channel current, no change in the nonstationary factual changes in the concentration of applied agonist. For CV is predicted with potentiation. However, CaMKII*-meexample, relief of partial physical blockade of the puffer diated potentiation of responses to kainate decreased the CV pipette or unintended movement of the puffer pipette toward (Fig. 7B) , consistent with an increase in the number of the target cell could masquerade as potentiation. To test AMPA receptors. The ratio of CV 02 before and after potentifor such possibilities, the duration of pressure injection of ation will be constant and equal to one for changes in singleagonist-containing solution was increased. This produced the channel current. Potentiation of kainate responses by expected increase in response size, but also resulted in a CaMKII* produced CV 02 ratio values greater than one, and longer-lasting response (Fig. 6A) . Decreasing the distance the ratio correlated with the amount of potentiation (Fig. between the tip of the puffer pipette and the cell also in-7C; regression analysis: P õ 0.05, R Å 0.89, n Å 8). Mean creased the magnitude of responses and altered their time potentiation for experiments used for CV analysis was course; in addition, the onset time of the response decreased 1.72 { 0.19. The mean change in CV 02 was 2.15 { 0.58. (Fig. 6B) .
The change in CV 02 was significantly different from 1 and In contrast to these possible artifactual effects, internal is therefore inconsistent with a hypothesis involving a change in single-channel conductance. perfusion of CaMKII* potentiated responses to kainate but J0286-7 / 9k20$$no58
10-31-97 15:12:04 neupa LP-Neurophys cifically potentiated kainate but not NMDA responsiveness. The maximal effect of kainate also was potentiated. Potentiation was not associated with a change in the time course of responses. Further, CaMKII* potentiation was accompanied by a decrease in the point-by-point CV.
These results confirm findings that increased postsynaptic CaMKII activity is sufficient to potentiate synaptic transmission in rodent hippocampus (Lledo et al. 1995; Pettit et al. 1994; Wang and Kelly 1995) and frog optic tectum (Wu et al. 1996) . In contrast to those studies, the patch perfusion technique used in the present study allowed direct comparison of responses before and after a delimited increase of CaMKII activity. Interestingly, CaMKII*-mediated potentiation occurred long after the typical ''washout'' period for LTP (Malinow and Tsien 1990) , implying that the processes underlying washout are before CaMKII activation. The delay between internal perfusion and potentiation varied from experiment to experiment; part of this delay may be attributable to diffusion of CaMKII* (33 kDa) to the synapses being stimulated.
Somatic receptors have been used previously as models for synaptic receptors (Jonas and Sakmann 1992; Tang et al. 1991; Wyllie et al. 1993) ; in this study, we assume that effects seen at somatic receptors will have analogous effects at synaptic receptors. We also assume that the observed changes of responses to kainate will be accompanied by similar changes of responses to endogenous transmitter. Two advantages of measuring responses to somatic application of agonist are that we have complete control over the distance between the application pipette and the response site and that diffusion of intrapipette perfusate to the cytoplasm underlying the response site is more rapid. Note that our application method is quite sensitive to distance. In fact, we were unable to evoke detectable responses with 100 mM kainate application unless the application pipette was within 10 mm of the cell membrane. Diffusion of kainate to greater distances (e.g., the dendrites) is thus unlikely to contribute significantly to the measured response. The greater magnitude of potentiation of somatic responses compared with synaptic responses might be due to the greater concentration of perfused CaMKII* in the soma compared with dendritic arbors and spines. Another possibility is that somatic AMPA/kainate receptors may be naive to CaMKII because FIG . 7. CaMKII* potentiation of responsiveness to non-NMDA agonists CaMKII is found in the highest concentration at the PSD is accompanied by a decrease in the nonstationary coefficient of variation Kennedy et al. 1983) and are therefore (CV) . A: 50 consecutive responses to kainate at 035 mV (fine line) and more sensitive to its effect. non-NMDA receptor-mediated responses (Figurov et al. 1993 ). Although we found that active CaMKII* had no D I S C U S S I O N specific effect on extra-synaptic NMDA responses, Kolaj et al. (1994) found that NMDA responses in dorsal horn neuTo summarize, perfusion of CaMKII* potentiated synaptic transmission and decreased failure rates. CaMKII* spe-rons potentiated when activated CaMKII was included in J0286-7 / 9k20$$no58 10-31-97 15:12:04 neupa LP-Neurophys patch solution. Different NMDA receptor subunit composi-that the voltage clamp was sufficiently intact and that a simple change in receptor affinity is unlikely to underlie tions in dorsal horn neurons and hippocampal CA1 neurons may explain this difference. In addition, Kolaj et al. did not potentiation by CaMKII*. Furthermore, the time course of responses is not changed. Increased receptor affinity for liuse internal perfusion; as a result, they could not have easily observed the rapid decrease of NMDA responsiveness im-gand also would be expected to produce longer lasting responses, which was not seen. Consistent with our analysis mediately after application of kinase solution. The rapid, kinase-independent decrease seen of NMDA responses pre-of CaMKII*-induced potentiation, previous studies have shown no change in binding affinity of AMPA receptors ceded appearance of RITC-dextran (40 kDa). This effect may have been mediated by calmodulin (10 kDa), a constit-after LTP (Maren et al. 1993) . A second hypothesis is that other rate constants of the channel change with CaMKII uent of both test and control perfusion solutions, which can down-regulate directly NMDA responses (Ehlers et al. activity . One specific change might be a decrease in the desensitization rate. Experiments with cyclothiazide demon-1996). Elucidation of this effect will require further studies. If the factor mediating this nonspecific effect can be found strate that decreasing desensitization and/or deactivation results in a slowing of time course of the kainate-evoked reand excluded, the effect of CaMKII* on synaptic NMDA responses could be measured directly.
sponses. CaMKII activation, in contrast, potentiates responses without changing time course, implying that To address mechanisms of potentiation, we attempted to obtain single-channel AMPA/kainate responses of outside-CaMKII does not potentiate transmission by reducing desensitization as cyclothiazide does. It is possible that a kinetic out patches while perfusing CaMKII*. However the signalto-noise resolution was not sufficient, likely due to the rela-change distinct from that mediating the cyclothiazide effect results in increased open probability; kinetic changes that tively small conductance of AMPA/kainate receptors (Edmonds et al. 1995) and the increase in noise produced by increase response size without affecting the macroscopic response time course are not ruled out by our results. Finally, the perfusion canula within the patch pipette. As an alternative, the time course and trial-to-trial variability of whole the hypothesis that the single-channel conductance of receptors increases with CaMKII activity would predict an incell currents were studied as a method of examining singlechannel properties (Hessler et al. 1993; Li et al. 1993 ; Lu crease in the mean response with no change in the nonstationary CV; our finding that CV decreases is evidence et Numann et al. 1991; Tang et al. 1991) . The finding that CaMKII*-mediated potentiation does not against this case.
A mechanism that would explain the findings of this study, change kainate response time course parallels the finding that the time course of non-NMDA synaptic responses does as well as many in the literature, is a specific increase in the number of active non-NMDA receptors after CaMKII not change during LTP (O'Connor et al. 1995) . Analysis of trial-to-trial variability showed that the CV 02 increased activation. Increasing the number of active receptors at synapses lacking active receptors would be manifested as the with potentiation; by itself, this finding is consistent with a change in channel number or open probability.
observed decrease in synaptic failure rate. More active receptors would increase the maximal effect of kainate. This Our results argue against several hypothetical mechanisms whereby CaMKII increases postsynaptic responsiveness in-mechanism of potentiation also would predict a direct ''scaling-up'' of responses, maintaining time course. In addition, directly. Selective potentiation of extrasynaptic non-NMDA responsiveness by CaMKII* is inconsistent with hypotheses it would decrease the nonstationary CV. Consistent with this view, LTP has been demonstrated to be coincident with an that CaMKII alters nonspecifically the membrane or signal conduction from the membrane to the soma. In addition, increase of the number of binding sites for AMPA without a change in binding affinity (Maren et al. 1993) . these data are inconsistent with hypotheses that require specialized synaptic elements after CaMKII activation to exThe exact mechanism by which such an increase in the number of active channels might occur is not elucidated press potentiation. The observation that potentiation of responses is concurrent with appearance of marker dye sug-by the experiments in this study, except that the necessary molecular machinery subsequent to CaMKII activation is gests that the effect of CaMKII* on non-NMDA responses is unlikely to be mediated by a series of messenger cascades not specific to synapses. The properties of several ligandgated channels are modified by direct phosphorylation (Mei or attributable to activation of transcription or translation. CaMKII has been demonstrated to phosphorylate directly and Si 1995; Raymond et al. 1993; Swope et al. 1992) .
Phosphorylation studies show that GluR1 is phosphorylated GluR1, a component of hippocampal non-NMDA receptors (Hayashi et al. 1997; McGlade-McCulloch et al. 1994; Tan by CaMKII (Hayashi et al. 1997; McGlade-McCulloch et al. 1993; Tan et al. 1994 ). Activation of previously silent et al. 1994), in the PSD as well as in vitro, supporting the hypothesis that CaMKII acts directly on AMPA/kainate channels may occur by changing open probability from 0 to a nonzero value or increasing conductance from 0 to a nonzero receptors to potentiate responsiveness during LTP.
The results presented here also constrain hypotheses for value. In addition, phosphorylation has been shown to induce acetylcholine receptor assembly (Green et al. 1991) as well specific potentiation of AMPA/kainate responsiveness. A simple hypothesis that the affinity of non-NMDA receptors as to cause active translocation of glucose transporters to the cell surface (Haruta et al. 1995; Pessin and Bell 1992) . increases is inconsistent with two observations. Tighter binding of ligand by receptors would be expected to have no The phosphorylation state of synapsin I influences targeting of presynaptic vesicles and is regulated by CaMKII (Llinas effect on a saturating dose of agonist. Although potentiation of saturated responses is smaller than potentiation of re-et al. 1991) . The phosphorylation state of the NR1 subunit of the NMDA receptor also has been shown to regulate its sponses to 10 mM kainate, the observation of significant potentiation of the maximal effect of kainate demonstrates localization . CaMKII phosphorylation J0286-7 / 9k20$$no58 10-31-97 15:12:04 neupa LP-Neurophys
